Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07201402 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Long Term Evaluation of Scapular-inserted Contraceptive Implants

StatusRecruiting
PhasePhase 2
Started2026-05-08
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 19 months later Oct 2027 → May 31, 2029
See other at-risk trials from Yale University

Amendment history

2026-10-02
Primary completion pushed: 2027-10 → 2029-05-31
Completion pushed: 2027-10 → 2029-05-31
2026-07-24
Study Status, Contacts/Locations v4
Study sitesdetails revised at 1 of 2 sites
2026-05-08
Study Status, Contacts/Locations v3
Recruitment opened
Start dateestimated 2026-03-15→confirmed 2026-05-08
Study sitesdetails revised at 2 of 2 sites
2026-04-09
Study Status, Eligibility v2
Eligibility criteria+590 characters
[...] ng the study Body-mass index ≥18.5kg/m2 Exclusion Criteria: ContradictionsSelf-reported contraindications to the use of the ENG implant based on the CDC Medical Elig [...] ast cancer Malignant liver tumor (hepatocellular carcinoma) KnownAllergic reaction to any components of the ENG implant Any self-reported known liver conditions that could affect drug metabolism (e.g., cirrhosis, hepatitis) Personal history of deep vein thrombosis (DVT), venous thromboembolism (VTE), or arterial thromboembolism (ATE). Currently taking and unable or unwilling to abstain from an [...] cations or supplements known to be CYP3 [...]
2026-02-12
Study Status v1
Start date2025-11→2026-03-15
2025-09-23
Original filing
Yale University
487 trials monitored
See 35 trials at risk
This study aims to evaluate long-term outcomes when the etonogestrel contraceptive implant is inserted at an alternative site located over the scapular. The study will evaluate the pharmacokinetics (i.e., drug levels) and side effect profiles of participants who have an etonogestrel contraceptive implant inserted at this alternative scapular site over the course of at least two years.
Trial Details
NCT Number NCT07201402
Lead Sponsor Yale University
Collaborators: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions Contraception
Enrollment 62 participants
Start Date 2026-05-08
Primary Completion 2029-05-31 (estimated)
Study Completion 2029-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-10-01